UNDA 240 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 240 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Equisetum arvense, Gentiana lutea, Salvia officinalis, Saxifraga granulata, Spiraea ulmaria
SUBSTANCE NAME: FILIPENDULA ULMARIA ROOT; SAGE; GENTIANA LUTEA ROOT; SAXIFRAGA GRANULATA FLOWERING TOP; EQUISETUM ARVENSE BRANCH
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-12-14
END MARKETING DATE: 0000-00-00


UNDA 240 HUMAN OTC DRUG Details:

Item DescriptionUNDA 240 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2016-12-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1161_43a3d9da-f7ea-2257-e054-00144ff8d46c
PRODUCT NDC: 62106-1161
APPLICATION NUMBER:

Other FILIPENDULA ULMARIA ROOT; SAGE; GENTIANA LUTEA ROOT; SAXIFRAGA GRANULATA FLOWERING TOP; EQUISETUM ARVENSE BRANCH Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 240